Biotech | November 30, 2022
Lonza collaborates with AbTis to extend Bioconjugation capabilities
Collaboration to implement AbTis’ AbClick platform into Lonza’s bioconjugation toolbox
Collaboration to implement AbTis’ AbClick platform into Lonza’s bioconjugation toolbox
It serves to leverage the strengths of various institutions to coordinate AMR surveillance lab networks
Program will fight the rising incidence of antimicrobial (drug) resistance and improve patient outcomes
Results reinforce commitment to next-generation oral SERD development programme
The TBDA is a collaboration established among biopharmaceutical companies, research organizations and universities to accelerate the discovery and development of novel therapeutic candidates against TB.
This first joint plan on One Health aims to create a framework to integrate systems and capacity so that we can collectively better prevent, predict, detect, and respond to health threats
New material distribution will serve medical device and pharmaceutical packaging manufacturers.
Glenmark is the first company in India to launch Thiazolidinedione Lobeglitazone (0.5 mg).
This will give a boost to cost-effective, quality medicines and contribute towards reduction in out of pocket expenditure on healthcare for the citizens
NCDC branches in States/UTs will provide a boost to Public Health Infrastructurewith prompt surveillance, rapid detection and timely monitoring of diseases enabling Early Interventions
Subscribe To Our Newsletter & Stay Updated
